North America Allergy Treatment Market

Market Introduction

The allergies are hypersensitive responses from human immune system to the substance that come in contact with body. Severe allergy can be life threatening which disturb the normal functioning of organs such as asthma causes poor functioning of lungs. The most effective treatment for allergy is to avoid the known allergens, while there are medications such as steroids and antihistamines and other therapies which prevent allergies.

Market Overview and Dynamics

The North America allergy treatment market is expected to reach US$ 10,940.67 million by 2028 from US$ 6,646.04 million in 2020; it is estimated to grow at a CAGR of 6.5% from 2021 to 2028. The growth of the market is attributed to increasing adoption of immunotherapy in allergy treatment, and developments in food allergy treatments. However, the lack of awareness about allergy treatments is a key factor restraining the market growth.

Key Market Segments

The North America Allergy treatment market, based on the allergy type was segmented into eye allergy, rhinitis, asthma, skin allergy, food allergies, and other allergies. In 2020, the rhinitis segment held the largest share of the market, whereas the food allergies segment is expected to grow at the fastest rate during the coming years.

The North America Allergy treatment market, based on the treatment was segmented into anti-allergy drugs, and immunotherapy. In 2020, the anti-allergy drugs segment held the largest share of the market. However, the immunotherapy is expected to grow at the fastest rate during the coming years.

Major Sources and Companies Listed

A few of the primary and secondary sources associated with this report on the North America allergy treatment market are American Academy of Allergy, Asthma, & Immunology (AAAAI), Asthma and Allergy Foundation of America (AAA), and National Institutes of Health (NIH).

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis of North America allergy treatment market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the North America allergy treatment market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within the North America allergy treatment market.

NORTH AMERICA ALLERGY TREATMENT MARKET SEGMENTATION

By Allergy Type:

• Eye Allergy
• Rhinitis
• Asthma
• Skin Allergy
• Food Allergies
• Other Allergies

By Treatment:

• Anti-Allergy Drugs

• Antihistamines
• Corticosteroids
• Decongestants
• Other Drugs

• Immunotherapy

• Sub-cutaneous Immunotherapy (SCIT)
• Sub-Lingual Immunotherapy (SLIT)

By Country

• US
• Canada
• Mexico

Company Profiles

• Johnson and Johnson Services, Inc.
• Sanofi
• AbbVie's Inc.
• Pfizer
• ALK-Abelló A/S
• Allergy Therapeutics
• Stallergenes Greer
• GlaxoSmithKline PLC

North America Allergy Treatment Market Strategic Insights

North America Allergy Treatment Market Segmentation Analysis

North America Allergy Treatment Market Report Highlights

North America Allergy Treatment Report Scope

North America Allergy Treatment Market Country and Regional Insights